- Home
- CNTB vs RPTX Comparison
CNTB vs RPTX Comparison
Compare CNTB & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- RPTX
- Stock Information
- Founded
- CNTB 2012
- RPTX 2016
- Country
- CNTB United States
- RPTX Canada
- Employees
- CNTB N/A
- RPTX N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- CNTB Health Care
- RPTX Health Care
- Exchange
- CNTB Nasdaq
- RPTX Nasdaq
- Market Cap
- CNTB 43.2M
- RPTX 38.3M
- IPO Year
- CNTB 2021
- RPTX 2020
- Fundamental
- Price
- CNTB $0.78
- RPTX $1.37
- Analyst Decision
- CNTB Strong Buy
- RPTX Strong Buy
- Analyst Count
- CNTB 1
- RPTX 3
- Target Price
- CNTB $8.00
- RPTX $4.50
- AVG Volume (30 Days)
- CNTB 212.7K
- RPTX 473.0K
- Earning Date
- CNTB 03-31-2025
- RPTX 05-27-2025
- Dividend Yield
- CNTB N/A
- RPTX N/A
- EPS Growth
- CNTB N/A
- RPTX N/A
- EPS
- CNTB N/A
- RPTX N/A
- Revenue
- CNTB $26,033,000.00
- RPTX $53,477,000.00
- Revenue This Year
- CNTB N/A
- RPTX N/A
- Revenue Next Year
- CNTB N/A
- RPTX N/A
- P/E Ratio
- CNTB N/A
- RPTX N/A
- Revenue Growth
- CNTB N/A
- RPTX 4.58
- 52 Week Low
- CNTB $0.51
- RPTX $0.89
- 52 Week High
- CNTB $2.08
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- CNTB 50.56
- RPTX 60.23
- Support Level
- CNTB $0.76
- RPTX $1.33
- Resistance Level
- CNTB $0.85
- RPTX $1.45
- Average True Range (ATR)
- CNTB 0.05
- RPTX 0.08
- MACD
- CNTB -0.00
- RPTX 0.00
- Stochastic Oscillator
- CNTB 26.00
- RPTX 65.31
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.